Biomunex Pharmaceuticals’ Agreement with Onward Therapeutics and Series A Fundraising

Dechert advised Biomunex Pharmaceuticals on the deal.Biomunex Pharmaceuticals, a French biopharmaceutical company, closed a strategic exclusive worldwide license and co-development agreement with Onward Therapeutics SA for…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now